KK
TGTX icon

KLP Kapitalforvaltning’s TG Therapeutics TGTX Stock Holding History

KLP Kapitalforvaltning’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Hold
33,200
– – 0.01% 822
2026
Q1 		$1.1M Buy
33,200
+1,200
+4% +$35.8K ﹤0.01% 978
2025
Q4 		$954K Buy
32,000
+1,200
+4% +$39.2K ﹤0.01% 1056
2025
Q3 		$1.11M Hold
30,800
– – ﹤0.01% 968
2025
Q2 		$1.11M Buy
30,800
+2,200
+8% +$81.9K ﹤0.01% 933
2025
Q1 		$1.13M Sell
28,600
-2,100
-7% -$70.7K 0.01% 875
2024
Q4 		$924K Buy
+30,700
New +$881K ﹤0.01% 1031

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

KLP Kapitalforvaltning's TGTX Position: Q2 2026 in Review

KLP Kapitalforvaltning held its TG Therapeutics (TGTX) position steady in Q2 2026 at 33,200 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #822.

KLP Kapitalforvaltning first reported a position in TGTX in Q4 2024 and has held it in 7 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • KLP Kapitalforvaltning held 33,200 shares of TG Therapeutics worth $1.82M as of Q2 2026.
  • KLP Kapitalforvaltning left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #822 holding.
  • KLP Kapitalforvaltning first reported a position in TG Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.